BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29863727)

  • 1. Maximizing the impact of microphysiological systems with in vitro-in vivo translation.
    Cirit M; Stokes CL
    Lab Chip; 2018 Jun; 18(13):1831-1837. PubMed ID: 29863727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.
    Edington CD; Chen WLK; Geishecker E; Kassis T; Soenksen LR; Bhushan BM; Freake D; Kirschner J; Maass C; Tsamandouras N; Valdez J; Cook CD; Parent T; Snyder S; Yu J; Suter E; Shockley M; Velazquez J; Velazquez JJ; Stockdale L; Papps JP; Lee I; Vann N; Gamboa M; LaBarge ME; Zhong Z; Wang X; Boyer LA; Lauffenburger DA; Carrier RL; Communal C; Tannenbaum SR; Stokes CL; Hughes DJ; Rohatgi G; Trumper DL; Cirit M; Griffith LG
    Sci Rep; 2018 Mar; 8(1):4530. PubMed ID: 29540740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating Biosensors in Organs-on-Chip Devices: A Perspective on Current Strategies to Monitor Microphysiological Systems.
    Ferrari E; Palma C; Vesentini S; Occhetta P; Rasponi M
    Biosensors (Basel); 2020 Aug; 10(9):. PubMed ID: 32872228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Microphysiological Systems: Transferable Organ Models and Recirculating Flow.
    Renggli K; Rousset N; Lohasz C; Nguyen OTP; Hierlemann A
    Adv Biosyst; 2019 May; 3(5):e1900018. PubMed ID: 32627410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the power of microphysiological systems for COVID-19 research.
    Kleinstreuer N; Holmes A
    Drug Discov Today; 2021 Nov; 26(11):2496-2501. PubMed ID: 34332095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian hormone control in a human-on-a-chip: In vitro biology's ignored component?
    Cyr KJ; Avaldi OM; Wikswo JP
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1714-1731. PubMed ID: 29065796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
    Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
    ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emergence of Microphysiological Systems (Organs-on-chips) as Paradigm-changing Tools for Toxicologic Pathology.
    Rudmann DG
    Toxicol Pathol; 2019 Jan; 47(1):4-10. PubMed ID: 30407146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.
    Wang YI; Carmona C; Hickman JJ; Shuler ML
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29205920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
    Hughes DJ; Kostrzewski T; Sceats EL
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-contained, low-cost Body-on-a-Chip systems for drug development.
    Wang YI; Oleaga C; Long CJ; Esch MB; McAleer CW; Miller PG; Hickman JJ; Shuler ML
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1701-1713. PubMed ID: 29065797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging microphysiological systems: a review.
    Peel S; Jackman M
    Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
    Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
    ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal microphysiological systems.
    Blutt SE; Broughman JR; Zou W; Zeng XL; Karandikar UC; In J; Zachos NC; Kovbasnjuk O; Donowitz M; Estes MK
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1633-1642. PubMed ID: 28534432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of tumor chip technology.
    Hachey SJ; Hughes CCW
    Lab Chip; 2018 Sep; 18(19):2893-2912. PubMed ID: 30156248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry.
    Baudy AR; Otieno MA; Hewitt P; Gan J; Roth A; Keller D; Sura R; Van Vleet TR; Proctor WR
    Lab Chip; 2020 Jan; 20(2):215-225. PubMed ID: 31799979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasingly microphysiological models.
    Nat Biomed Eng; 2019 Jul; 3(7):491-492. PubMed ID: 31278390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.